Status:

UNKNOWN

Cerebral Small Vessel Disease and Perioperative Covert Stroke

Lead Sponsor:

RenJi Hospital

Conditions:

Cerebral Small Vessel Diseases

Covert Postoperative Stroke

Eligibility:

All Genders

65-85 years

Brief Summary

MOCSS study is a multicenter prospective clinical cohort study. The purpose of the MOCSS study is to investigate whether there is a correlation between the preoperative cerebral small vessel disease a...

Detailed Description

With the growing number of the older population, surgery for elderly patients is on the rise. Elderly patients often have more cardiovascular disease and brain vulnerability and tend to experience mor...

Eligibility Criteria

Inclusion

  • Age from 65 years to 85 years;
  • The patient is about to have major surgery for the first time and the operation is non-cardiac surgery;
  • Written informed consent is obtained before the surgery.

Exclusion

  • mental illness;
  • Already have other diseases that can cause dementia, such as Alzheimer's disease, Lewy body dementia, Frontotemporal dementia, progressive supranuclear palsy, Parkinson's disease, Creutzfeldt-Jakob disease, Huntington's disease, alcohol and drug dependence, Neurosyphilis, systemic lupus erythematosus; or preoperative MRI shows hippocampal and temporal lobe atrophy more than two levels, suggesting the possibility of Alzheimer's disease
  • Have suffered from other brain diseases (such as stroke, multiple sclerosis, central nervous system infection with sequelae, etc.);
  • Preoperative MRI indicates covert stroke
  • MMSE or MoCA scale cannot be completed due to other reasons (such as hearing impairment or visual impairment)
  • MRI contraindications before or after surgery or patients who cannot tolerate MRI imaging
  • Stage 3 or 4 malignant tumors, and high malignancy and poor prognosis cancer, such as pancreatic cancer, gallbladder cancer, and bile duct cancer.

Key Trial Info

Start Date :

August 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

548 Patients enrolled

Trial Details

Trial ID

NCT04443933

Start Date

August 1 2020

End Date

December 1 2023

Last Update

June 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Renji Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, China